Five Prime Therapeutics, Inc. Reports Discovery of IL-34
SAN FRANCISCO--(BUSINESS WIRE)--In this week’s edition of the journal Science, researchers at Five Prime Therapeutics, Inc. report the discovery of Interleukin-34, a novel cytokine, as well as the identification of an IL-34 receptor.